{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "DJ-1 mutations are associated with early onset Parkinson's disease, and L166P is a point mutation in helical region near dimer interface that destabilizes protein function.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states DJ-1 is involved in parkinsonism through its loss of function mutations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No specific assay details provided for L166P mutation.",
          "judgment": "Do not use PS3/BS3",
          "reasoning": "No information on assays used or controls."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_very_strong",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "L166P is likely pathogenic as it destabilizes the DJ-1 protein, leading to parkinsonism."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "M26I variant was found to be non-functional and likely pathogenic as it disrupts dimerization despite partial proteasome inhibition rescue.",
          "judgment": "Yes",
          "reasoning": "M26I's disruption of dimerization suggests involvement in parkinsonism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Proteasome inhibition experiment showed partial rescue, indicating a functional impact.",
          "judgment": "Yes",
          "reasoning": "The ability to dimerize is crucial for function."
        },
        {
          "step_name": "Step 3: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Partial proteasome inhibition rescue suggests partial loss of function.",
          "judgment": "PS3_supporting",
          "reasoning": "Some functional impact but not complete."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_supporting",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "M26I is pathogenic with moderate evidence supporting its role in parkinsonism."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "R",
          "alt": "Q",
          "position": "98"
        },
        "variant_string_id": "DJ-1 R98Q"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "R98Q mutation did not have significant effect on protein function.",
          "judgment": "Yes",
          "reasoning": "No mention of functional impact."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No specific functional data provided for R98Q.",
          "judgment": "Do not use PS3/BS3",
          "reasoning": "Insufficient information."
        }
      ],
      "final_evidence_strength": {
        "type": "BS3_supporting",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "R98Q is benign as it does not show significant functional impact."
    }
  ]
}